ACTIVE

MEDILOM & C°

Financial year 2025 · Closed on 31/12/2025

Net result32,5 k €-76,5 %over 1 year
Gross margin225,5 k €-20,2 %over 1 year
Equity353,3 k €+10,1 %over 1 year
Workforce1,8 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

MEDILOM & C° is a Public limited company incorporated in 1991. Its registered office is in Antwerpen. It employs on average 1,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0444.191.902
Incorporation
15/05/1991
Legal form
Public limited company
Registered office
Meirbrug 1
2000 Antwerpen · FlandreSee on map
Contributed capital
62 000,00 €
Latest accounts
31/12/2025
Average workforce
1,8 ETP
Joint committees (1)
  • 226
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

20252024202320222021
Income statement
Gross margin225,5 k €282,7 k €121,1 k €114,1 k €115,5 k €
EBITDA107,9 k €170,2 k €-424,6 €24 k €30,4 k €
Operating result107,1 k €168,4 k €24,9 k €24,3 k €-455,2 €
Net result32,5 k €138,2 k €10,6 k €33,7 k €33,9 k €
Balance sheet
Equity353,3 k €320,8 k €182,5 k €172 k €138,2 k €
Total assets735,5 k €696,6 k €442,2 k €570,1 k €503,6 k €
Cash265,4 k €321,8 k €107 k €277,1 k €191,2 k €
Debts381,5 k €354,9 k €207,8 k €396,1 k €349,4 k €
Other
Workforce1,8 ETP1,8 ETP2,0 ETP2,0 ETP2,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 20 ended

Active mandates

Victor Medellin Herrera

Director · since 01 mars 2019

Active

Ended mandates

Mederez Pharmaceuticals LLC BO

Director · since 01 mars 2019 · until 08 juin 2025

Represented by Victor Medellin Herrera

Ended
Victor Medellin Herrera

Managing director · since 01 mars 2019 · until 08 juin 2025

Ended
Farchem BO

Director · since 08 juin 2018 · until 08 juin 2024 · 0836.987.660

Represented by Michael Milgrom

Ended
Farchem BO

Managing director · since 08 juin 2018 · until 28 février 2019

Represented by Michael Milgrom

Ended

Other companies at this address

Meirbrug 1 2000 Antwerpen
CompanyCBE no.
0798.898.730
0897.522.291
ALEYA INVEST● Active
0795.336.256
ANMOR LABELS● Active
0676.441.178
Ballet● Active
0783.663.790
CONIMMO● Active
0893.371.879
0632.764.652
d'Asbestgekeurd● Active
1033.293.686
d’Asvastgoed● Active
1040.766.646
1021.105.637
DJEFRY● Bankrupt
0731.953.189
0695.696.965
D.P. DEVELOPMENT● Bankrupt
0471.674.475
0885.924.754
0632.558.081
EVO● Active
0828.687.133
GD INVEST● Bankrupt
0476.127.963
GOLDEN PRETZEL● Active
0769.635.810
Interdean● Liquidation
0404.761.796
0417.250.052

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date08/07/202624/07/202524/07/202429/06/202305/07/202221/07/2021
General meeting12/06/202627/06/202514/06/202409/06/202310/06/202211/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202512/06/202608/07/2026DutchPDF
Abridged model31/12/202427/06/202524/07/2025DutchPDF
Abridged model31/12/202314/06/202424/07/2024DutchPDF
Abridged model31/12/202209/06/202329/06/2023DutchPDF
Abridged model31/12/202110/06/202205/07/2022DutchPDF
Abridged model31/12/202011/06/202121/07/2021DutchPDF
Abridged model31/12/201912/06/202028/08/2020DutchPDF
Abridged model31/12/201828/02/201920/08/2019DutchPDF
Abridged model31/12/201708/06/201820/08/2018DutchPDF
Abridged model31/12/201609/06/201731/07/2017DutchPDF
Abridged model31/03/201609/09/201627/10/2016DutchPDF
Abridged model31/03/201511/09/201514/09/2015DutchPDF
Abridged model31/03/201412/09/201425/09/2014DutchPDF
Abridged model31/03/201313/09/201330/10/2013DutchPDF
Abridged model31/03/201214/09/201230/10/2012DutchPDF
Abridged model31/03/201109/09/201113/09/2011DutchPDF
Abridged model31/03/201010/09/201029/10/2010DutchPDF
Abridged model31/03/200911/09/200928/10/2009DutchPDF
Abridged model31/03/200812/09/200831/10/2008DutchPDF
Abridged model31/03/200714/09/200729/10/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 20 ended

Active mandates

Victor Medellin Herrera

Director · since 01 mars 2019

Active

Ended mandates

Mederez Pharmaceuticals LLC BO

Director · since 01 mars 2019 · until 08 juin 2025

Represented by Victor Medellin Herrera

Ended
Victor Medellin Herrera

Managing director · since 01 mars 2019 · until 08 juin 2025

Ended
Farchem BO

Director · since 08 juin 2018 · until 08 juin 2024 · 0836.987.660

Represented by Michael Milgrom

Ended
Farchem BO

Managing director · since 08 juin 2018 · until 28 février 2019

Represented by Michael Milgrom

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates29/12/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates10/09/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/02/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other13/12/2016
    BOEKJAAR - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates16/02/2016
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates04/01/2013
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates27/06/2011
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates27/06/2011
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202532,5 k €↓
  2. 2024
    Annual accounts 2024138,2 k €↑
  3. 2023
    Annual accounts 202310,6 k €↓
  4. 2022
    Annual accounts 202233,7 k €↓
  5. 2021
    Annual accounts 202133,9 k €↓
  6. 2021
    Name changeMEDILOM
  7. 2020
    Annual accounts 202035,4 k €↑
  8. 2019
    Annual accounts 2019277,9 €↑
  9. 2018
    Annual accounts 2018-132,5 k €↓
  10. 2017
    Annual accounts 2017-86,3 k €↓
  11. 2016
    Annual accounts 201638,2 k €↓
  12. 2016
    Annual accounts 2016160,5 k €↓
  13. 2016
    Name changeMEDILOM & C°
  14. 2015
    Annual accounts 2015326,2 k €↑
  15. 2014
    Annual accounts 20142,9 k €↑
  16. 2013
    Annual accounts 2013-5 k €↓
  17. 2012
    Annual accounts 2012-2,7 k €↑
  18. 2011
    Annual accounts 2011-14,1 k €↑
  19. 2010
    Annual accounts 2010-64,3 k €↑
  20. 2008
    Annual accounts 2008-192,4 k €↓
  21. 2007
    Annual accounts 20071,5 k €
  22. 2007
    Name changeMEDILOM AND CO
  23. 15/05/1991
    IncorporationPublic limited company